
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 National Cancer Centre; 2 Agenica Research; and 3 Genome Institute of Singapore, Singapore, Republic of Singapore
Requests for reprints: Patrick Tan, National Cancer Centre, 11 Hospital Drive, 169610 Singapore, Republic of Singapore. Phone: 65-6-436-8345; Fax: 65-6-226-5694; E-mail: cmrtan{at}nccs.com.sg.
Purpose: Previous reports using genome-wide gene expression data to classify breast tumors have typically used standard unsupervised or supervised techniques, both of which have known limitations. We hypothesized that novel clinically relevant information could be revealed in these data sets by an alternative analytic approach. Using a recently described algorithm, signature analysis (SA), we identified "modules," comprising groups of tightly coexpressed genes that are conditionally linked to particular tumors, in a series of breast tumor gene expression profiles.
Experimental Design and Results: The SA successfully identified multiple breast cancer modules specifically linked to distinct biological functions. We identified a novel module, TuM1, whose presence was not readily discernible by conventional clustering techniques. The TuM1 module is expressed in a subset of estrogen receptor (ER)positive tumors and is significantly enriched with genes involved in apoptosis and cell death. Clinically, TuM1-expressing tumors are associated with low histopathologic grade, and this association is independent of the inherent ER status of a tumor. We confirmed the robustness and general applicability of TuM1 module by demonstrating its association with low tumor grade in multiple independent breast cancer data sets generated using different array technologies. In vitro, the TuM1 module is down-regulated in ER+ MCF7 cells upon treatment with tamoxifen, suggesting that TuM1 expression may be dependent on active signaling by ER. Initial data is also suggestive that TuM1 expression may be clinically associated with a patient's response to antihormonal therapy.
Conclusion: Our results suggest that modular-based approaches toward gene expression data can prove useful in identifying novel, robust, and biologically relevant signatures even from data sets that have been the subject of substantial prior analysis.
This article has been cited by other articles:
![]() |
M. Lupien, J. Eeckhoute, C. A. Meyer, S. A. Krum, D. R. Rhodes, X. S. Liu, and M. Brown Coactivator Function Defines the Active Estrogen Receptor Alpha Cistrome Mol. Cell. Biol., June 15, 2009; 29(12): 3413 - 3423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Closas and S. Chanock Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status Clin. Cancer Res., December 15, 2008; 14(24): 8000 - 8009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chanrion, V. Negre, H. Fontaine, N. Salvetat, F. Bibeau, G. M. Grogan, L. Mauriac, D. Katsaros, F. Molina, C. Theillet, et al. A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer Clin. Cancer Res., March 15, 2008; 14(6): 1744 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K.T. Tan, L. K. Tan, K. Yu, P. H. Tan, M. Lee, L. H. Sii, C. Y. Wong, G. H. Ho, A. W.Y. Yeo, P. K.H. Chow, et al. Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer Clin. Cancer Res., January 15, 2008; 14(2): 461 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wei and H. Li A Markov random field model for network-based analysis of genomic data Bioinformatics, June 15, 2007; 23(12): 1537 - 1544. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |